127 related articles for article (PubMed ID: 20874815)
1. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder.
Zhan L; Kerr JR; Lafuente MJ; Maclean A; Chibalina MV; Liu B; Burke B; Bevan S; Nasir J
Neuropathol Appl Neurobiol; 2011 Feb; 37(2):206-19. PubMed ID: 20874815
[TBL] [Abstract][Full Text] [Related]
2. Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients.
Vogel M; Pfeifer S; Schaub RT; Grabe HJ; Barnow S; Freyberger HJ; Cascorbi I
Neuropsychobiology; 2004; 50(4):305-10. PubMed ID: 15539862
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex.
Baracskay KL; Haroutunian V; Meador-Woodruff JH
Synapse; 2006 Sep; 60(4):271-9. PubMed ID: 16786528
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins.
Bai J; He F; Novikova SI; Undie AS; Dracheva S; Haroutunian V; Lidow MS
Biol Psychiatry; 2004 Sep; 56(6):427-40. PubMed ID: 15364041
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
[TBL] [Abstract][Full Text] [Related]
6. The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder.
Torres KC; Souza BR; Miranda DM; Nicolato R; Neves FS; Barros AG; Dutra WO; Gollob KJ; Correa H; Romano-Silva MA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):214-9. PubMed ID: 19059449
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans.
Chase DL; Pepper JS; Koelle MR
Nat Neurosci; 2004 Oct; 7(10):1096-103. PubMed ID: 15378064
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report.
Wong DF; Wagner HN; Pearlson G; Dannals RF; Links JM; Ravert HT; Wilson AA; Suneja S; Bjorvvinssen E; Kuhar MJ
Psychopharmacol Bull; 1985; 21(3):595-8. PubMed ID: 4034877
[No Abstract] [Full Text] [Related]
9. Dopamine D3 receptor gene not associated with symptomatology of major psychoses.
Serretti A; Lattuada E; Cusin C; Lilli R; Lorenzi C; Smeraldi E
Am J Med Genet; 1999 Oct; 88(5):476-80. PubMed ID: 10490702
[TBL] [Abstract][Full Text] [Related]
10. Gene and expression analyses reveal enhanced expression of pericentrin 2 (PCNT2) in bipolar disorder.
Anitha A; Nakamura K; Yamada K; Iwayama Y; Toyota T; Takei N; Iwata Y; Suzuki K; Sekine Y; Matsuzaki H; Kawai M; Miyoshi K; Katayama T; Matsuzaki S; Baba K; Honda A; Hattori T; Shimizu S; Kumamoto N; Tohyama M; Yoshikawa T; Mori N
Biol Psychiatry; 2008 Apr; 63(7):678-85. PubMed ID: 17884020
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of the gene coding for DARPP-32 (PPP1R1B) in Japanese patients with schizophrenia or bipolar disorder.
Yoshimi A; Takahashi N; Saito S; Ito Y; Aleksic B; Usui H; Kawamura Y; Waki Y; Yoshikawa T; Kato T; Iwata N; Inada T; Noda Y; Ozaki N
Schizophr Res; 2008 Mar; 100(1-3):334-41. PubMed ID: 18055181
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D4 receptors elevated in schizophrenia.
Seeman P; Guan HC; Van Tol HH
Nature; 1993 Sep; 365(6445):441-5. PubMed ID: 8413587
[TBL] [Abstract][Full Text] [Related]
13. Molecular evidence for mitochondrial dysfunction in bipolar disorder.
Konradi C; Eaton M; MacDonald ML; Walsh J; Benes FM; Heckers S
Arch Gen Psychiatry; 2004 Mar; 61(3):300-8. PubMed ID: 14993118
[TBL] [Abstract][Full Text] [Related]
14. Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain.
Seeman P; Ko F; Jack E; Greenstein R; Dean B
Synapse; 2007 May; 61(5):303-9. PubMed ID: 17318883
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor D4 gene is not associated with major psychoses.
Serretti A; Lilli R; Di Bella D; Bertelli S; Nobile M; Novelli E; Catalano M; Smeraldi E
Am J Med Genet; 1999 Oct; 88(5):486-91. PubMed ID: 10490704
[TBL] [Abstract][Full Text] [Related]
16. Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction.
Guitart-Masip M; Johansson B; Fernández-Teruel A; Cañete T; Tobeña A; Terenius L; Giménez-Llort L
Neuroscience; 2006 Nov; 142(4):1231-43. PubMed ID: 17008016
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of the genetic background of bipolar disorder and schizophrenia (introduction)].
Gábor G
Neuropsychopharmacol Hung; 2007 Jun; 9(2):77-9. PubMed ID: 17970530
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.
Munakata K; Iwamoto K; Bundo M; Kato T
Biol Psychiatry; 2005 Mar; 57(5):525-32. PubMed ID: 15737668
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia.
Dean B; Keriakous D; Scarr E; Thomas EA
Aust N Z J Psychiatry; 2007 Apr; 41(4):308-20. PubMed ID: 17464717
[TBL] [Abstract][Full Text] [Related]
20. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons.
Errico F; Santini E; Migliarini S; Borgkvist A; Centonze D; Nasti V; Carta M; De Chiara V; Prosperetti C; Spano D; Herve D; Pasqualetti M; Di Lauro R; Fisone G; Usiello A
Mol Cell Neurosci; 2008 Feb; 37(2):335-45. PubMed ID: 18035555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
